...
首页> 外文期刊>Heart >Incidence and predictors of sudden cardiac death in patients with reduced left ventricular ejection fraction after myocardial infarction in an era of revascularisation
【24h】

Incidence and predictors of sudden cardiac death in patients with reduced left ventricular ejection fraction after myocardial infarction in an era of revascularisation

机译:血运重建时代心肌梗死后左心室射血分数降低的患者猝死的发生率和预测因素

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To determine the incidence and predictors of sudden-cardiac death (SCD) in the current era of revascularisation of myocardial infarction (MI) survivors with reduced LVEF. Methods A prospective observational study was conducted in FuWai Hospital from 2004 to 2009. A total of 1018 consecutive patients who had an LVEF ≤35% and New York Heart Association Class Ⅱ/Ⅲ heart failure at least 40 days after MI were enrolled if they were not available for implantation of an implantable cardioverter defibrillator. The degree of coronary artery disease and revascularisation were analysed. The primary outcome was SCD and secondary outcome was all-cause death. Results During a mean follow-up of 2.8 years, the SCD rate was 5% and all-cause mortality was 7.4%. The annual incidence of SCD was 1.8%. Kaplan-Meier analysis showed that the cumulative rate of SCD was significantly increased in patients with triple-vessel disease (6.7% vs 0.6%), left main coronary disease (10.3% vs 4.1%), EF ≤ 25% (8.3% vs 3.9%) and non-revascularisation therapy (9.6% vs 2.7%) (all logrank, p<0.05). After multivariable Cox regression analysis, the risk of SCD was predicted by age (HR 1.05, 95% CI 1.02 to 1.09), EF ≤25% (HR 1.82, 95% CI 1.04 to 3.21) and non-revascularisation (HR 3.97, 95% CI 2.15 to 7.31). Conclusions Revascularisation may reduce the risk of SCD in post-MI patients with an LVEF ≤35% on the basis of medical therapy, and the increased risk for SCD may be predicted by age, LVEF ≤25% and non-revascularisation.
机译:目的确定在当前LVEF降低的心肌梗死(MI)幸存者血运重建时代中,心脏猝死(SCD)的发生率和预测指标。方法2004年至2009年在阜外医院进行前瞻性观察研究。入选了MI患者至少40天后LVEF≤35%且纽约心脏协会Ⅱ/Ⅲ级心力衰竭的1018例连续患者。不适用于植入式心脏复律除颤器。分析了冠状动脉疾病和血运重建的程度。主要结果是SCD,次要结果是全因死亡。结果在平均2.8年的随访中,SCD率为5%,全因死亡率为7.4%。 SCD的年发病率为1.8%。 Kaplan-Meier分析显示,三血管疾病,左主干冠状动脉疾病(10.3%和4.1%),EF≤25%(EF≤25%)(8.3%和3.9)的患者,SCD的累积率显着增加。 %)和非血运重建治疗(9.6%vs 2.7%)(所有对数秩,p <0.05)。经过多变量Cox回归分析后,可以根据年龄(HR 1.05,95%CI 1.02至1.09),EF≤25%(HR 1.82,95%CI 1.04至3.21)和非血运重建(HR 3.97,95)预测SCD的风险%CI 2.15至7.31)。结论在药物治疗的基础上,血运重建可降低LVEF≤35%的心梗后患者发生SCD的风险,并且可通过年龄,LVEF≤25%和不进行血运重建来预测SCD风险的增加。

著录项

  • 来源
    《Heart》 |2014年第16期|1242-1249|共8页
  • 作者单位

    State Key Laboratory of Cardiovascular Disease, Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China;

    Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, Beijing 100037, China;

    Department of Cardiology, Hangzhou First People's Hospital and Hangzhou Hospital of Nanjing Medical University, Hangzhou, China;

    State Key Laboratory of Cardiovascular Disease, Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China;

    State Key Laboratory of Cardiovascular Disease, Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China;

    State Key Laboratory of Cardiovascular Disease, Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China;

    State Key Laboratory of Cardiovascular Disease, Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China;

    State Key Laboratory of Cardiovascular Disease, Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号